Literature DB >> 20403707

IL-6 and IL-1 synergistically enhanced the production of MMPs from synovial cells by up-regulating IL-6 production and IL-1 receptor I expression.

Miho Suzuki1, Misato Hashizume, Hiroto Yoshida, Masashi Shiina, Masahiko Mihara.   

Abstract

In the present study, we investigated potential synergism between IL-6 and IL-1 for the production of matrix metalloproteinases (MMPs) by the synovial cell line SW982. Cells were cultured with different combinations of IL-6, soluble IL-6 receptor (sIL-6R) and IL-1beta for 24h and production of MMPs was then measured. IL-6+sIL-6R, but not IL-6 alone, induced MMP-13 and MMP-3 production. IL-1beta also induced production of MMPs. Of interest, addition of IL-6+sIL-6R together with IL-1beta synergistically increased MMP production. Next, we analyzed the mechanism responsible for the synergistic effects of IL-6+sIL-6R and IL-1beta in combination. IL-1beta-induced MMP production was significantly augmented in the presence of sIL-6R. IL-1beta as well as IL-6+sIL-6R induced IL-6 production. Moreover, IL-6+sIL-6R significantly augmented expression of IL-1RI, but not IL-1RII, in SW982 cells. Responsiveness to IL-1beta was much higher in IL-6+sIL-6R-pretreated cells than non-treated cells in terms of MMP production. Finally, IL-6+sIL-6R-induced IL-1RI expression was inhibited by a STAT pathway inhibitor, but not a MAPK pathway inhibitor. These results suggest that increased expression of IL-1RI stimulated by IL-6+sIL-6R and the increased production of IL-6 on exposure to IL-1beta and IL-6+sIL-6R are involved in the observed synergistic effect on the production of MMPs by SW982 cells. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20403707     DOI: 10.1016/j.cyto.2010.03.017

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  15 in total

1.  Intercellular adhesion molecule-1 on synovial cells attenuated interleukin-6-induced inhibition of osteoclastogenesis induced by receptor activator for nuclear factor κB ligand.

Authors:  M Suzuki; M Hashizume; H Yoshida; M Shiina; M Mihara
Journal:  Clin Exp Immunol       Date:  2010-10-29       Impact factor: 4.330

2.  Potential role of fibroblast-like synoviocytes in joint damage induced by Brucella abortus infection through production and induction of matrix metalloproteinases.

Authors:  Romina Scian; Paula Barrionuevo; Guillermo H Giambartolomei; Emilio A De Simone; Silvia I Vanzulli; Carlos A Fossati; Pablo C Baldi; M Victoria Delpino
Journal:  Infect Immun       Date:  2011-07-05       Impact factor: 3.441

3.  Histone deacetylase inhibitor vorinostat (SAHA, MK0683) perturb miR-9-MCPIP1 axis to block IL-1β-induced IL-6 expression in human OA chondrocytes.

Authors:  Mohammad S Makki; Tariq M Haqqi
Journal:  Connect Tissue Res       Date:  2016-07-12       Impact factor: 3.417

4.  Harpagoside suppresses IL-6 expression in primary human osteoarthritis chondrocytes.

Authors:  Abdul Haseeb; Mohammad Yunus Ansari; Tariq M Haqqi
Journal:  J Orthop Res       Date:  2016-05-04       Impact factor: 3.494

Review 5.  Selected cytokine pathways in rheumatoid arthritis.

Authors:  Mélissa Noack; Pierre Miossec
Journal:  Semin Immunopathol       Date:  2017-02-17       Impact factor: 9.623

6.  A Polyphenol-rich Pomegranate Fruit Extract Suppresses NF-κB and IL-6 Expression by Blocking the Activation of IKKβ and NIK in Primary Human Chondrocytes.

Authors:  Abdul Haseeb; Nazir M Khan; Omer S Ashruf; Tariq M Haqqi
Journal:  Phytother Res       Date:  2017-03-09       Impact factor: 5.878

7.  Baseline anti-citrullinated peptide antibody (ACPA) titers and serum interleukin-6 (IL-6) levels possibly predict progression of bone destruction in early stages of rheumatoid arthritis (ERA).

Authors:  Yukihiko Saeki; Eriko Kudo-Tanaka; Shiro Ohshima; Masato Matsushita; So-ichiro Tsuji; Yu-ichi Maeda; Maiko Yoshimura; Akane Watanabe; Yoshinori Katada; Yoshinori Harada; Kenji Ichikawa; Yasuo Suenaga; Yusuke Ohta; Shigeto Tohma
Journal:  Rheumatol Int       Date:  2012-03-29       Impact factor: 2.631

8.  Blockade of interleukin-6 receptor enhances the anti-arthritic effect of glucocorticoids without decreasing bone mineral density in mice with collagen-induced arthritis.

Authors:  M Suzuki; H Yoshida; M Hashizume; K Tanaka; Y Matsumoto
Journal:  Clin Exp Immunol       Date:  2015-08-31       Impact factor: 4.330

Review 9.  Inflammation induced loss of skeletal muscle.

Authors:  Priya Londhe; Denis C Guttridge
Journal:  Bone       Date:  2015-11       Impact factor: 4.398

10.  The roles of interleukin-6 in the pathogenesis of rheumatoid arthritis.

Authors:  Misato Hashizume; Masahiko Mihara
Journal:  Arthritis       Date:  2011-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.